Halper Sadeh LLC is investigating the $32.50 per share sale of Baldwin Group, the $7.75 per share sale of CCC Intelligent Solutions, and the $36.50 per share sale of Pacira BioSciences for potential fiduciary breaches.
The stock is subject to a pending $32.50 per share all-cash sale to Sequence Holdings and DFO Management, so the price should trade near the deal price. A routine shareholder-rights law firm investigation into potential fiduciary breaches is common in mergers and rarely changes deal economics; a possible upside is pressure for increased consideration.
CCC has a pending $7.75 per share cash sale to affiliates of GTCR and Elliott Investment Management L.P., anchoring the share price to the offer. The law firm investigation is a routine merger inquiry without quantified claims, so it is unlikely to move the price materially in the coming days to weeks.
Pacira has agreed to a $36.50 per share cash sale to Viatris Inc., which will pin the share price near that level. The routine investigation by a shareholder-rights firm contains no new hard facts about deal value or terms, so the expected price effect is minimal.
Law firm Halper Sadeh LLC announced investigations into the proposed acquisitions of Baldwin Group, CCC Intelligent Solutions, and Pacira BioSciences. The firm is reviewing potential breaches of fiduciary duties regarding the cash-per-share terms offered in each transaction.
$32.50 in cash per share, in a sale to Sequence Holdings and DFO Management.
No. The law firm is only investigating potential violations and seeking increased consideration, disclosures, or other relief; the article does not say the transaction is blocked.
$7.75 in cash per share from affiliates of GTCR and Elliott Investment Management L.P.
The law firm says it may seek increased consideration or additional disclosures, but the article gives no indication the price will actually be raised.
$36.50 per share in cash by Viatris Inc.
Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, on a contingent fee basis.